يعرض 1 - 10 نتائج من 147 نتيجة بحث عن '"Strick-Marchand, Hélène"', وقت الاستعلام: 1.22s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Immunité Innée - Innate Immunity, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Centre d'Ingénierie génétique murine - Mouse Genetics Engineering Center (CIGM), Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), The work was supported in part by grants from the European Union's Horizon 2020 research and innovation program under grant agreement no. 847939, and from the ANRS-MIE Agence Nationale de Recherches sur le Sida et les Hépatites Virales/Maladies Infectieuses Emergentes (grant ECTZ91652) (to HS-M). PB acknowledges funding from the French National Research Agency grants ANR-18-CE15-0001 project Autoimmuni-B, from the Institut Carnot Pasteur Microbes et Santé, from the Institut Pasteur and from the Institut National de la Santé et de la Recherche Médicale (INSERM). FJ is employed by the Centre National de la Recherche Scientifique (CNRS). AT received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie (Grant Agreement No. 765104)., ANR-18-CE15-0001,Autoimmuni-B,Etude de la rupture de tolérance dans une maladie humaine autoimmune médiée par les lymphocytes B(2018), European Project: 765104,MATURE-NK

    المصدر: ISSN: 0014-2980.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37621208; info:eu-repo/grantAgreement//765104/EU/MAnufacturing of TUmour-REactive Natural Killer cells/MATURE-NK; pasteur-04225194; https://pasteur.hal.science/pasteur-04225194Test; https://pasteur.hal.science/pasteur-04225194/documentTest; https://pasteur.hal.science/pasteur-04225194/file/Eur%20J%20Immunol%20-%202023%20-%20Thaller.pdfTest; PUBMED: 37621208

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Laboratoire d’innovation : vaccins – Innovation lab : vaccines, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Université Paris Cité (UPCité), National Center for Genetic Engineering and Biotechnology Thailand (BIOTEC), National Science and Technology Development Agency Bangkok (NSTDA), VIROxIS Villejuif, Institut Gustave Roussy (IGR), Lyssavirus, épidémiologie et neuropathologie - Lyssavirus Epidemiology and Neuropathology, Institut de Recherche Biomédicale des Armées Brétigny-sur-Orge (IRBA), Génomique évolutive des virus à ARN - Evolutionary genomics of RNA viruses, Génétique de la souris - Mouse Genetics, Neuropathologie expérimentale / Experimental neuropathology, Immunité Innée - Innate Immunity, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Funding for “Outbreak Response to Novel Coronavirus (COVID-19): Development of a vaccine against novel coronavirus SARS-CoV-2 using the clinical Phase III measles vector technology” project was provided by the Coalition for Epidemic Preparedness Innovations (CEPI). The development of the mouse-adapted MacO3 virus was funded by the ANR-20-COVI-0028-01 grant program. P.N.F. was supported by the ANR-18-CE17-0004-01 programme, Recherche translationnelle en santé. Part of this work was supported by Institut Pasteur TASK FORCE SARS COV2 (NicoSARS and NeuroCovid projects)., We thank Anastassia Komarova, Vincent Enouf and Sylvie Van Der Werf from the RNA Viruses Molecular Genetics Unit of Institut Pasteur for helpful discussions and SARS-Cov-2 virus information. We thank Maud Vanpeene and Vincent Enouf from the Mutualized Platform of Microbiology, Pasteur International Bioresources Network for viral sequencing. We thank Victoire Perraud and Simon Bonas from the Lyssavirus Epidemiology and Neuropathology Unit for their help with animal experiments and RNA extraction. We thank Audrey Ferrier, Annabelle Garnier, and Laurence Cheutin from the Armed Forces Biomedical Research Institute (IRBA) for handling the serums cohort from SARS-Cov-2 convalescent patients., ANR-20-COVI-0028,HuMoCID,Développement de modèles murins de COVID-19(2020), ANR-18-CE17-0004,ComboVaxEm,Des vaccins combinés contre les infections virales émergentes(2018)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

  5. 5
    دورية أكاديمية

    المساهمون: National Institute of Allergy and Infectious Diseases, Burroughs Wellcome Fund

    المصدر: Gastroenterology ; volume 160, issue 5, page 1437-1442 ; ISSN 0016-5085

    مصطلحات موضوعية: Gastroenterology, Hepatology

  6. 6
    دورية أكاديمية

    المساهمون: Emory University School of Medicine, Emory University Atlanta, GA, Morphogénèse et antigénicité du VIH, des Virus des Hépatites et Emergents (MAVIVHe), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunité Innée - Innate Immunity, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported in part by NIH Grant 1-R01-AI-132833(RFS), and 5P30-AI-50409 (CFAR)(RFS), by Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) Grants #2016-16180 and #2016-16365, European Commission Seventh Framework Programme PATHCo(HEALTH-F3-2012-305578), Institut Pasteur, and Institut national de la santé et de la recherche médicale (HSM), by ANRS and Institut national de la santé et de la recherche médicale (INSERM) (HDR)., European Project: 305578,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,PATHCO(2012)

    المصدر: ISSN: 0066-4804.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31712213; info:eu-repo/grantAgreement/EC/FP7/305578/EU/Pathogen COinfection:HIV, Tuberculosis, Malaria and Hepatitis C virus/PATHCO; pasteur-02875583; https://pasteur.hal.science/pasteur-02875583Test; https://pasteur.hal.science/pasteur-02875583/documentTest; https://pasteur.hal.science/pasteur-02875583/file/Antimicrobial%20Agents%20and%20Chemotherapy-2019-Amblard-AAC.01701-19.full.pdfTest; PUBMED: 31712213

  7. 7
    دورية أكاديمية

    المساهمون: Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology, Institut Pasteur Paris (IP), F. Hoffmann-La Roche Basel, Immunité Innée - Innate Immunity, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Investigation Clinique et d’Accès aux Ressources Biologiques (Plate-forme) - Clinical Investigation and Access to BioResources (ICAReB), Biologie Intégrée du Globule Rouge (BIGR (UMR_S_1134 / U1134)), Institut National de la Transfusion Sanguine Paris (INTS)-Université de La Réunion (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre / Abymes Guadeloupe -Université des Antilles (UA)-Université Paris Cité (UPCité), Centre de Recherche Translationnelle - Center for Translational Science (CRT), H. Mouquet received core grants from the G5 Institut Pasteur Program, the Milieu Intérieur Program (ANR-10-LABX-69-01) and INSERM. This work was funded by Institut Roche. V. Hehle and M. Beretta were supported by postdoctoral fellowships from Roche. V. Hehle and T. Hieu were also supported by the European Research Council–Seventh Framework Program (ERC-2013-StG 337146). H. Strick-Marchand was supported by the Institut Pasteur and Agence Nationale de Recherches sur le Sida et les Hépatites Virales (2016-16365, 2019-19241)., We are grateful to members of the Center for Translational Sciences (Institut Pasteur), Cassandre Von Platen (Clinical core) for the preparation of the RAPIVIB protocol, and Gloria Morizot (Investigation Clinique et Accès aux Ressources Biologiques) for collecting biological samples and associated personal data. We also thank Sandrine Schmutz, Sophie Novault (UTechS CB, Center for Translational Sciences, Institut Pasteur), and Ayrin Kök for their technical help with single cell sorting, and Dr. J. Aguilar (Center for Genetic Engineering and Biotechnology, Havana, Cuba) for providing us with the purified adw HBsAg particles., ANR-10-LABX-0069,MILIEU INTERIEUR,GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE(2010), European Project: 337146,EC:FP7:ERC,ERC-2013-StG,HUMANTIVIRUSES(2014)

    المصدر: ISSN: 0022-1007.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32579155; info:eu-repo/grantAgreement/EC/FP7/337146/EU/Human Antibody Responses to Viruses/HUMANTIVIRUSES; pasteur-03242779; https://pasteur.hal.science/pasteur-03242779Test; https://pasteur.hal.science/pasteur-03242779/documentTest; https://pasteur.hal.science/pasteur-03242779/file/jem_20200840.pdfTest; PUBMED: 32579155; PUBMEDCENTRAL: PMC7537403

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Institut Pasteur, Agence Nationale de la Recherche, Seventh Framework Programme, Gilead Sciences, Institut National de la Santé et de la Recherche Médicale

    المصدر: European Journal of Immunology ; volume 49, issue 6, page 954-965 ; ISSN 0014-2980 1521-4141

  10. 10

    المساهمون: Laboratoire d’innovation : vaccins – Innovation lab : vaccines, Institut Pasteur [Paris], Université de Paris (UP), National Center for Genetic Engineering and Biotechnology [Thailand] (BIOTEC), National Science and Technology Development Agency [Bangkok] (NSTDA), VIROxIS [Villejuif], Institut Gustave Roussy (IGR), Lyssavirus, épidémiologie et neuropathologie - Lyssavirus Epidemiology and Neuropathology, Institut de Recherche Biomédicale des Armées (IRBA), Génomique évolutive des virus à ARN - Evolutionary genomics of RNA viruses, Génétique de la souris - Mouse Genetics, Neuropathologie expérimentale / Experimental neuropathology, Institut Pasteur [Paris]-Université de Paris (UP), Immunité Innée - Innate Immunity, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Funding for 'Outbreak Response to Novel Coronavirus (COVID-19): Development of a vaccine against novel coronavirus SARS-CoV-2 using the clinical Phase III measles vector technology' project was provided by the Coalition for Epidemic Preparedness Innovations (CEPI). The development of the mouse-adapted MacO3 virus was funded by the ANR-20-COVI-0028-01 grant program. P.N.F. was supported by the ANR-18-CE17-0004-01 programme, Recherche translationnelle en santé. Part of this work was supported by Institut Pasteur TASK FORCE SARS COV2 (NicoSARS and NeuroCovid projects)., We thank Anastassia Komarova, Vincent Enouf and Sylvie Van Der Werf from the RNA Viruses Molecular Genetics Unit of Institut Pasteur for helpful discussions and SARS-Cov-2 virus information. We thank Maud Vanpeene and Vincent Enouf from the Mutualized Platform of Microbiology, Pasteur International Bioresources Network for viral sequencing. We thank Victoire Perraud and Simon Bonas from the Lyssavirus Epidemiology and Neuropathology Unit for their help with animal experiments and RNA extraction. We thank Audrey Ferrier, Annabelle Garnier, and Laurence Cheutin from the Armed Forces Biomedical Research Institute (IRBA) for handling the serums cohort from SARS-Cov-2 convalescent patients., ANR-20-COVI-0028,HuMoCID,Développement de modèles murins de COVID-19(2020), ANR-18-CE17-0004,ComboVaxEm,Des vaccins combinés contre les infections virales émergentes(2018), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Hardy, David, Développement de modèles murins de COVID-19 - - HuMoCID2020 - ANR-20-COVI-0028 - COVID-19 - VALID, APPEL À PROJETS GÉNÉRIQUE 2018 - Des vaccins combinés contre les infections virales émergentes - - ComboVaxEm2018 - ANR-18-CE17-0004 - AAPG2018 - VALID, Institut de Recherche Biomédicale des Armées [Brétigny-sur-Orge] (IRBA)

    المصدر: Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
    Nature Communications
    Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.6277. ⟨10.1038/s41467-021-26506-2⟩
    Nature Communications, 2021, 12 (1), pp.6277. ⟨10.1038/s41467-021-26506-2⟩

    وصف الملف: application/pdf